1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BEEEB2ECD17EA0A98525782B0059DC6E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/BEEEB2ECD17EA0A98525782B0059DC6E!OpenDocument
18
19OpenDocument
2018.206.14.36
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Resource Allocation

Complimentary Excerpt: Winning in the U.S. Marketplace: Pre-launch and Launch Investment Benchmarks for New Products

DB Image

ID: MD-234


Features:

Metrics


Pages/Slides: 4


Published: Pre-2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5122 "Winning in the U.S. Marketplace: Pre-launch and Launch Investment Benchmarks for New Products."


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Consumer Products; Medical Device; Biotech


Companies Profiled:
Abbott; Bayer Healthcare; Sanofi-aventis; Merck; Roche; Bristol-Myers Squibb; Inspire Pharmaceuticals; Novo Nordisk; EMD Serono; GlaxoSmithKline; Onyx Pharmaceuticals; Shire; Amylin; Bausch & Lomb; Noven Therapeuticals; ProStrakan; Xanodyne Pharmaceuticals; Genzyme; Teva Neuroscience; Lundbeck; Regeneron; Baxter Healthcare; Astellas

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.